Epistasis as a Determinant of the HIV-1 Protease's Robustness to Mutation

被引:1
|
作者
Capel, Elena
Parera, Mariona
Angel Martinez, Miguel [1 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, Fundacio IrsiCaixa, Badalona, Spain
来源
PLOS ONE | 2014年 / 9卷 / 12期
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; DELETERIOUS MUTATIONS; REVERSE-TRANSCRIPTASE; REPLICATION CAPACITY; CATALYTIC EFFICIENCY; GENETIC ROBUSTNESS; FITNESS LANDSCAPE; IN-VITRO; EVOLUTION; PROTEIN;
D O I
10.1371/journal.pone.0116301
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The robustness of phenotypes to mutation is critical to protein evolution; robustness may be an adaptive trait if it promotes evolution. We hypothesised that native proteins subjected to natural selection in vivo should be more robust than proteins generated in vitro in the absence of natural selection. We compared the mutational robustness of two human immunodeficiency virus type 1 (HIV-1) proteases with comparable catalytic efficiencies, one isolated from an infected individual and the second generated in vitro via random mutagenesis. Single mutations in the protease (82 and 60 in the wild-type and mutant backgrounds, respectively) were randomly generated in vitro and the catalytic efficiency of each mutant was determined. No differences were observed between these two protease variants when lethal, neutral, and deleterious mutations were compared (P=0.8025, chi-squared test). Similarly, average catalytic efficiency (-72.6% and -64.5%, respectively) did not significantly differ between protease mutant libraries (P=0.3414, Mann Whitney test). Overall, the two parental proteins displayed similar mutational robustness. Importantly, strong and widespread epistatic interactions were observed when the effect of the same mutation was compared in both proteases, suggesting that epistasis can be a key determinant of the robustness displayed by the in vitro generated protease.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Epistasis among Deleterious Mutations in the HIV-1 Protease
    Parera, Mariona
    Perez-Alvarez, Nuria
    Clotet, Bonaventura
    Angel Martinez, Miguel
    JOURNAL OF MOLECULAR BIOLOGY, 2009, 392 (02) : 243 - 250
  • [2] HIV-1 protease inhibitors and mechanisms of HIV-1's resistance
    Das, Debananda
    GLOBAL HEALTH & MEDICINE, 2024, 6 (06): : 357 - 362
  • [3] Evidence for positive epistasis in HIV-1
    Bonhoeffer, S
    Chappey, C
    Parkin, NT
    Whitcomb, JM
    Petropoulos, CJ
    SCIENCE, 2004, 306 (5701) : 1547 - 1550
  • [4] A new logic correlation rule for HIV-1 protease mutation
    Lin, Yi-Chun
    Huang, Yueh-Min
    Leu, James Jiunn-Yin
    EXPERT SYSTEMS WITH APPLICATIONS, 2011, 38 (05) : 5448 - 5455
  • [5] Predominance of positive epistasis among drug resistance-associated mutations in HIV-1 protease
    Zhang, Tian-hao
    Dai, Lei
    Barton, John P.
    Du, Yushen
    Tan, Yuxiang
    Pang, Wenwen
    Chakraborty, Arup K.
    Lloyd-Smith, James O.
    Sun, Ren
    PLOS GENETICS, 2020, 16 (10):
  • [6] Comment on "Evidence for positive epistasis in HIV-1''
    Wang, K
    Mittler, JE
    Samudrala, R
    SCIENCE, 2006, 312 (5775)
  • [7] A multivariate analysis of HIV-1 protease inhibitors and resistance induced by mutation
    Almerico, AM
    Tutone, M
    Lauria, A
    Diana, P
    Barraja, P
    Montalbano, A
    Cirrincione, G
    Dattolo, G
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (01) : 168 - 179
  • [8] HIV-1 protease inhibitor
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (06) : 261 - 261
  • [9] HIV-1 Protease Cleavages
    Abdullah, Muhammad
    Khawaja, Seher Ansar
    Farooq, Muhammad
    4TH INTERNATIONAL CONFERENCE ON INNOVATIVE COMPUTING (IC)2, 2021, : 873 - +
  • [10] INHIBITORS OF HIV-1 PROTEASE
    MEEK, TD
    JOURNAL OF ENZYME INHIBITION, 1992, 6 (01): : 65 - 98